Abnormal uterine bleeding is a common sign of a number of different uterine disorders ranging from dysfunctional (non organic) abnormalities or complications of pregnancy to organic lesions such as polyps, hyperplasia or carcinoma. 1 A practical approach to the possible diagnosis associated with abnormal bleeding takes age i n t o a c c o u n t . P r e g n a n c y -r e l a t e d a n d dysfunctional disorders are more common in younger patients whereas atrophy and organic lesions become more frequent in older Methods: This is a retrospective study conducted at Hospital of 2nd author during a period of 5 years (Jan 2008-Dec 2013. Histopathology records were retrieved and searched for cases of abnormal uterine bleeding. Relevant histopathological findings and clinical data were recorded and analyzed. The aim of the study was to determine the causes for abnormal uterine bleeding in women presenting to the hospital and to compare the histopathological findings at various age groups. Results: The age of patients ranged from 17 to 71 years with an average of 43 years. The most common cause of uterine bleeding was found to be proliferative phase endometrium; that were 649 cases (56.43%). Out of the pathological causes, the most common cause was found to be endometrial hyperplasia-44 cases (3.82%). Endometrial carcinoma was found to be more common in the elderly postmenopausal women. A total of 6 cases (0.5%) of endometrial carcinoma were present.
INTRODUCTION
Atrophy and carcinoma occur more frequently in patients older than 60 years of age, whereas polyps and hyperplasia are more common in patients who are perimenopausal or recently postmenopausal. 3, 4 Ideally, the clinical history that accompanies an endometrial sample should include some description of the pattern and the amount of bleeding. 5 A history of anovulation, obesity, hypertension, diabetes and exogenous estrogen use should alert the pathologist that the patient is at an increased risk for hyperplasia and adenocarcinoma. 6 As the endometrium is responsive to hormones, the history of hormone use is important information. Clinical uses of steroid hormones (estrogen, progesterone or both) i n c l u d e o r a l c o n t r a c e p t i v e u s e , p o s t menopausal replacement therapy and therapy for endometriosis, hyperplasia, DUB, infertility and breast carcinoma. 7 Abnormal and excessive endometrial bleeding without structural pathology occurs in reproductive women of all ages but is more common in adolescent and perimenopausal women. 8, 9 The present study was carried out to determine the causes for abnormal uterine bleeding in women presenting in hospital to which second author is affiliated and to compare the histopathological findings at various age groups.
METHODS
This was a retrospective cross-sectional study conducted for a duration of 5 years (Jan 2008- 
RESULTS
The majority of the patients were in the age group of 40-50 years; 391 cases (34%). The least number of cases were below the age group of 20 years-05 cases. (0.43%). (Table 1) The most common cause of uterine bleeding was found to be proliferative phase endometrium -649 cases (56.43%). Out of the pathological causes, the most common cause The incidence of atypical and adenomatous hyperplasia however increased in these studies. 12 This is explained by the fact that the incidence of endometrial carcinoma was also high in these studies. The more severe the hyperplasia, the more likely it is to be followed by endometrial carcinoma. In the case of simple hyperplasia, the risk is very small.
Conversely, the incidence of carcinoma in women with complex and atypical hyperplasia has been in the neighborhood of 15-30%. 13 The lower frequency of atypical and adenomatous hyperplasia in our study can be explained by the fact that Nepalese women practice early childbearing and multiparity leading to a much longer resting (inactive state) of the endometrium. Further there is also a reduced incidence of carcinoma in this study.
(0.5%)
The normal physiological pattern of proliferative phase endometrium -649 (56.43%) was slightly higher as compared to 48% reported by Nadoss 14 . Other studies quoted a marked decreased incidence as 24%, 25% and 26% 10, 11 .
The incidence of atrophic endometrium in our study was 217 (18.86%). Postmenopausally, DUB is frequently associated with an atrophic endometrium-an unprepared endometrium resulting from inadequate secretion of estrogen. 9 The incidence of chronic endometritis was less-0.5% as compared to 24% in other studies. 10, 11 Chronic endometritis characterized by an infiltrate of lymphocytes and plasma cells usually follows pregnancy or abortion and use of intracontraceptive device (IUCD) 9 Frequency of endometrial polyp was slightly lesser-0.6% as compared to 3.2% in a study conducted in Pakistan. 10 Use of hormonal pills also predispose to a condition known as pill endometrium, especially use of progestational agents. Pill pattern endometrium was almost the same-3%
as that as 2.8%. 10 Oral contraceptive pills and hormonal use predispose to endometrial hyperplasia.
As the women get old, the incidence of structural abnormality including malignancy increases. 16 A total of 6 (0.5%) cases in our study had endometrial carcinomas. Out of the 6 cases, 2 cases were diagnosed as adeno- De Cherney in the department of Gynae in the cancer institute, Japan showed an incidence of endometrial carcinoma as 2.8%. 18 The incidence of endometrial carcinoma is comparable to other studies except a study conducted in Chinese population which showed a high incidence of 50%. 17 The lower incidence of endometrial carcinoma in Nepalese women may be due to the practice of early childbearing and multiparity leading to a much longer resting (inactive state) during pregnancy. 19 
CONCLUSIONS
Endometrial hyperplasia and malignancies are common in increasing age group, especially in perimenopausal and postmenopausal women.
So, a thorough work-up and diagnostic endometrial biopsy is therefore mandatory without delay in these patients to rule out malignancies.
